Back to top

Vaxart reports data from sentinel safety cohort of oral COVID-19 vaccine trial

Vaxart (VXRT) announced topline data from the approximately 400-participant sentinel safety cohort of its Phase 2b clinical trial evaluating the co...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

VAXART, INC. (VXRT)